Blastocyst development
スポンサーリンク
概要
- 論文の詳細を見る
The advantages of blastocyst transfer in mid-good responders include a reduction in multiple pregnancies due to single good-quality blastocyst transfer and an elevation of implantation and ongoing pregnancy rates due to establishment of the vitrification method. However, evidence is lacking as to whether blastocyst culture is effective in poor responders. In fact, few centers have adopted blastocyst transfer for all patients. Blastocyst development rate is around 50-60%. Several kinds of commercial sequential media are currently available and almost all Assisted Reproductive Technology (ART) units use these for treatment of patients. However, the period in which these media can be used is limited to 26-70 days according to the instructions provided by manufacturers. The half-life of pyruvate and antibiotics is supposedly short, and vitamins and hormones are unstable. Ideally, centers would make and use their own media within 72 h. In the near future, optimal ovarian stimulation, culture conditions, embryo transfer and luteal support should enable the possibility of providing healthy pregnancy following single blastocyst transfer in almost all patients.
- Japan Society for Immunology of Reproductionの論文
Japan Society for Immunology of Reproduction | 論文
- Toll-like receptors: 形態形成から生体防御に関与するレセプター群
- 遺伝子導入技術の進歩と治療応用
- Heterogeneity of antiphospholipid antibodies in identical twins
- Analysis for microdeletions in the AZFc region of the Y chromosome in Japanese azoospermic and oligozoospermic men
- Heterogeneity of antiphospholipid antibodies in identical twins